Sep 22, 2026 9 0
Uploaded by Genevieve
Favorite
Share
More Options
9
Real-World Study of EGFR-TKI Rechallenge With Another TKI After First-Line Osimertinib Discontinuation in Patients With EGFR-Mutated Non-Small Cell Lung Cancer - A Subset Analysis of the Reiwa Study_Page 1

Open in WPS to view all 9 pages